Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children

NCT02799615 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.

NCT NCT02799615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02799615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Phase
Observational
Overall status
Completed
Start date
May 31, 2016
Completion date
November 30, 2019
Enrollment
38 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

bowel diseases, inflammatory, colitis, ulcerative